In tumors with MYCN overexpression, as is the case of NB, interaction with CDK2 appears to be critical for senescence avoidance and immortalization [361], being associated with worse prognosis and considered a suitable therapeutic target in this tumor type [362,363]. This evidence concerns the gene MYCN and neuroblastoma.